Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2017Mar2016Mar2015
   EV/Core EBITDA(x) 18.2430.428.269.0016.56

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 18.24 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar202318.24
Mar202230.42
Mar20178.26
Mar20169.00
Mar201516.56

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26
-8.22
Mar2016 9
-45.65
Mar2015 16.56 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,314.1 Cr -2.6% 23.5% 129.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹114,614.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 2.2% -4.6% 86.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.6%

23.5%

129.3%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses